Deadline: November 30, 2012
The Global Alliance for TB Drug Development (TB Alliance) is a not-for-profit product development partnership accelerating the discovery and development of new tuberculosis (TB) drugs that will shorten treatment, be effective against drug susceptible and drug resistant strains, be compatible with antiretroviral therapies for HIV and improve treatment of latent infection. Working with public and private research organizations worldwide, the TB Alliance is leading the advancement of the largest portfolio of TB drug candidates in history, paving the way for the first new treatments in over 40 years. The TB Alliance is committed to ensuring that approved new regimens are affordable, adopted and available to those who need them.
What is the TB Alliance Stakeholders Association?
The TB Alliance Stakeholders Association includes a range of institutions worldwide that share a clear interest and a significant stake in ensuring the development of a faster, better cure for TB. The Stakeholders Association includes representatives from developing nations, public institutes, NGOs, professional organizations, donors, academia, foundations, industry and affected communities. Stakeholders advise, guide and support the TB Alliance; assist in the dissemination and sharing of relevant information; and participate in the TB Alliance’s fundraising, outreach and advocacy efforts. They also advise and support the Board of Directors on various matters, including activities related to adoption and availability of new TB regimens. These responsibilities are exercised through ongoing contact with the TB Alliance, the nomination of candidates for the Board of Directors, and the election of a Stakeholders Association President who holds an ex-officio position on the Board. The Stakeholders Association meets annually to review the TB Alliance’s progress and to provide feedback.
What does being the Community Representative of the Stakeholders Association entail?
The Community Representative holds a three-year term as a member of the Stakeholders Association and serves in his or her individual capacity, rather than representing an institution. The Community Representative is a voice for patients and represents the issues and viewpoints of communities directly affected by TB. The Community Representative provides feedback on all aspects of TB drug development and delivery and advises the TB Alliance on advocacy strategies and community involvement initiatives. The Community Representative attends the Annual Meeting and participates in various other Stakeholders Association initiatives throughout the year.
The Community Representative does not receive monetary compensation. Travel support is provided for the Community Representative to attend the Annual Meeting of the Stakeholders Association.
What is the process for selecting the Community Representative?
- Written application – Candidates that wish to be considered for the Community Representative are invited to submit applications by no later than November 30, 2012. The requirements of the application are explained in the application form.
- Phone interview – Short-listed candidates will be contacted to arrange a phone interview.
- Final decision – The selection committee, in collaboration with the Nominating Committee of the Association, will put forward a final candidate. Confirmation of the appointment will be determined by vote of the full membership of the Stakeholders Association. The confirmed Community Representative will be notified in early 2012 and the term of service will begin immediately.
- First-hand knowledge of the needs of people with TB or TB/HIV
- Active participation in organizations or networks working on TB or TB/HIV advocacy, treatment, education, treatment support or treatment literacy
- Ability to travel internationally to attend the Annual Meeting of the Stakeholders Association
- Technical understanding of issues related to drug development, clinical research and/or regulatory processes
- Understanding of political activism, advocacy and/or community mobilization
How to apply:
Candidates for Community Representative must submit a written application in English that contains the following:
- Completed application form
- Short Curriculum Vitae or biography outlining experience (maximum of 1 page)
- Signed letter of recommendation from an individual or institution who can speak to the candidate’s ability to serve as a Community Representative
Applications must be submitted by November 30, 2012 via email. Only complete applications will be considered. For questions about the application or the Community Representative selection process, please write to [email protected].